Motor neurone disease

BMJ

Volumn 318, Issue 7191, 1999, Pages 1118-

  Shaw, Pamela ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; ACETYLCYSTEINE; ALPHA TOCOPHEROL; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE INHIBITOR; CHELATING AGENT; CILIARY NEUROTROPHIC FACTOR; GABAPENTIN; GLUTATHIONE; LAMOTRIGINE; NEUROPROTECTIVE AGENT; PENICILLAMINE; RILUZOLE; SOMATOMEDIN C;

CLINICAL TRIAL; GENETICS; HUMAN; MOTOR NEURON DISEASE; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW; ANIMAL MODEL; GENE MUTATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY;

CLINICAL TRIALS; GLUTAMIC ACID; HUMANS; MOTOR NEURON DISEASE; NERVE DEGENERATION; OXIDATIVE STRESS;

EID: 0033599646     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7191.1118     Document Type: Article

References (28)

1. Rosen D.R. Siddique T. Patterson D. Figlewicz D.A. Sapp P. Hentati A. et al. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362:59–62.
2. Cookson MR Shaw PJ. Oxidative stress and motor neurone disease. Brain Pathol (in press).
3. Brown RH. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80:687–692.
4. Hentati A. Bejaoui K. Pericak-Vance M. Hentati F. Speer M.C. Hung W.Y. et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35.Nat Genet 1994; 7:425–428.
5. Chance P.F. Rabin B.A. Ryan S.G. Ding Y. Scavina M. Crain B. et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34.Am J Hum Genet 1998; 62:633–640.
6. Figlewicz D.A. Rouleau G.A. Krizus A. Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis.Hum Mol Genet 1994; 3:1757–1761.
7. Tomkins J. Usher P.A. Slade J.Y. Ince P.G. Curtis A. Bushby K. et al. Novel insertion in the KSP repeat region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS).Neuroreport (in press).
8. Comi G.P. Bordoni A. Salani S. Franceschina L. Scianno M. Prelle A. et al. Cytochrome c oxidase subunit 1 microdeletion in a patient with motor neuron disease.Ann Neurol 1998; 43:110–116.
9. Olkowski Z.L. Mutant A.P. endonuclease in patients with amyotrophic lateral sclerosis. Neuroreport 1998; 9:239–242.
10. Ferrante R.J. Brown S.E. Shinobu L.A. Bowling A.C. Baik M.J. MacGarvey U. et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.J Neurochem 1997; 69:2064–2074.
11. Shaw P.J. Ince P.G. Falkous G. Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38:691–695.
12. Shaw P.J. Chinnery R.M. Thagesen H. Borthwick G. Ince P.G. Immunocytochemical study of the distribution of the free radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1), Mn superoxide dismutase (Mn SOD) and catalase in the normal human spinal cord and in motor neurone disease.J Neurol Sci 1997; 147:115–125.
13. Aguirre T. Van den Bosch L. Goetschalckx K. Tilkin P. Mathijis G. Cassiman J.J. et al. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress.Ann Neurol 1998; 43:452–457.
14. Shaw P.J. Ince P.G. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 1997; 244(suppl 2): S3–14.
15. Rothstein J.D. Martin L.J. Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326:1464–1468.
16. Rothstein J.D. Van Kammen M. Levey A.I. Martin L.J. Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38:73–84.
17. Shaw P.J. Forrest V. Ince P.G. Richardson J.P. Wastell H.J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995; 4:209–216.
18. Lin C.L.G. Bristol L.A. Dykes-Hoberg M. Crawford T. Clawson L. Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter in amyotrophic lateral sclerosis. Neuron 1998; 20:589–602.
19. Nagai M. Abe K. Okamoto K. Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998; 244:165–168.
20. Shaw PJ Eggett CJ. Molecular factors underlying the selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol (in press).
21. Williams T.L. Day N.C. Ince P.G. Kamboj R.K. Shaw P.J. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.Ann Neurol 1997; 42:200–207.
22. Ince P.G. Stout N. Shaw P.J. Slade J. Hunziker W. Heizmann C.W. et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease.Neuropathol Appl Neurobiol 1993; 19:291–299.
23. Lacomblez L, Bensimon G, Leigh P.N., Guillet P, Meininger V, ALS/riluzole Study Group II.Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347:1425–1432.
24. Louwerse E.S. Weverling G.J. Bossuyt P.M.M. Posthumus Meyjes F.E. de Jong J.M.B.V. Randomized, double-blind controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995; 52:559–564.
25. Lai E.C. Felice K.J. Festoff B.W. Gawel M.J. Gelinas D.F. Kratz R. et al. Effect of recombinant human insulin-like growth factor-1 on progression in ALS. Neurology 1997; 49:1621–1630.
26. Gurney M.E. Cutting F.B. Zhai P. Doble A. Taylor C.P. Andrus P.K. et al. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.Ann Neurol 1996; 39:147–158.
27. Kostic V. Jackson-Lewis V. deBilbao F. Dubois-Dauphin M. Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277:559–562.
28. Ghadge G.D. Lee J.P. Bindokas V.P. Jordan J. Ma L. Miller R.J. et al. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection.J Neurosci 1997; 17:8756–8766.